Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Chemists Recruit Anthrax to Deliver Cancer Drugs
With some tinkering, a deadly protein becomes an efficient carrier for antibody drugs.
Biologists Find An Early Sign Of Cancer
Patients show boost in certain amino acids years before diagnosis of pancreatic cancer.
Protein ‘Map’ Could Lead to Potent New Cancer Drugs
Findings will help scientists to design drugs that could target NMT enzyme.
New Approach Aims to Silence Cancer ‘Survival Genes’
Scientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death.
DNA in ‘Gene Deserts’ Linked with Breast Cancer
Non-coding DNA raised the risk of breast cancer by affecting the activity of key genes.
Inivata Raises £4m to Realize the Potential of ctDNA Analysis
New spin-out from Cancer Research UK launched with funding from Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation.
Reversing The Effects Of Pulmonary Fibrosis
Study shows potential for reversing the effects of pulmonary fibrosis with a microRNA mimic.
Gene Expression Patterns in Pancreatic CTCs Revealed
Distinct patterns of gene expression in several groups of CTCs were identified, including significant differences from the primary tumor that may contribute to the ability to generate metastases and prove to be targets for improved treatment of the deadly tumor.
Promise for Treatment of Pancreatic Cancer
Ultrasound microbubbles can improve tumor absorption of cancer drugs.
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
Scroll Up
Scroll Down
Return
Your body is 3D, why is your cell culture not?
Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH
Date Posted: Friday, October 11, 2013
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Tecan Provides Automated Solutions for Molecular Pharmacology
Leibniz-Institut uses Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries.
Tuesday, July 06, 2010
Screening Center Chooses Tecan for Reliability and Support
The University of Chicago’s CSC is using Tecan’s Freedom EVO® workstations to provide high throughput cell screening services.
Friday, June 11, 2010
Tecan Platforms Improve Microarray Throughput and Research Quality in South Africa
South African researchers have established a high throughput biological research platform with a number of automated microarray processing systems from Tecan.
Friday, February 22, 2008
High Throughput Screening of Infectious Virus Entry in Mammalian Cells
Researchers at Swiss Federal Institute of Technology are using two customized Tecan Freedom EVO® 200 liquid handling workstations to silence 7,000 mammalian genes.
Thursday, June 07, 2007
Tecan Boosts RNA Work in France
Tecan's Freedom EVO® Workstation has been used to develop automated in vitro selection techniques for identifying and isolating aptamers.
Wednesday, March 29, 2006
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv